Status:
NOT_YET_RECRUITING
Cell Population Data in CLPD and Viral Disease
Lead Sponsor:
Assiut University
Conditions:
Chronic Lymphoproliferative Disease
Eligibility:
All Genders
19-75 years
Brief Summary
Hematological malignancies typically arise from two major blood cell lineages: lymphoid and myeloid cells . Hematological malignancies are the fourth most frequently diagnosed cancer around the world ...
Eligibility Criteria
Inclusion
- 1-Age \> 18 years old 2- Patient newly diagnosed CLPD according to the recent WHO classification; based on bone marrow examination, immunophenotyping \&/or LN biopsy 3- Patients are newly diagnosed with viral hepatitis infection based on viral serology
Exclusion
- 1- patient on treatment 2- Patient has both chronic lymphoproliferative disorders and viral hepatitis infection 3- Patient has any other' hematological disease 4- Patient has any chronic disease affect hematological parameters. 5- patient with incomplete medical records
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT06893640
Start Date
May 1 2025
End Date
June 1 2026
Last Update
March 25 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.